Skip to evidence report

FIB.adventitial.complement_angiocrine: Studies — page 6

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 5,164 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 5,001–6,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.adventitial.complement_angiocrine
#Trait / studyIndividual trait IDMean IC score
5001PACS2 levelsGCST904701410.36
5002Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17ECGA0000170.36
5003MCFD2/VSIR ratioGCST903154110.36
5004MPIG6B/SUSD1 ratioGCST903154870.36
5005Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027750.36
5006CST3 levelsUKBB000001630.36
5007Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377ECGA0003770.36
5008CASP7 levelsGCST904685470.36
5009TBCB levelsGCST904708130.36
5010AMY1A or AMY1B or AMY1C levelsGCST904682970.35
5011EFNB2 levelsGCST904690820.35
5012X-12749 levelsGCST902437700.35
5013LACRT levelsGCST904697250.35
5014PRKAR1A levelsGCST904703260.35
5015DKK1/VTA1 ratioGCST903144850.35
5016T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83)GCST903206460.35
5017CNST/DOK2 ratioGCST903141570.35
5018AXL/MCAM ratioGCST903134210.35
5019Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381ECGA0003810.35
5020Haematocrit percentage | Blood countUKBB000002920.35
5021CD79B/CKAP4 ratioGCST903138980.35
5022Triacylglycerol_54:5_[M+NH4]1+ levelsGCST900605390.35
5023APOD levelsGCST904683370.35
5024PSME2 levelsGCST904703610.35
5025EHD3 levelsGCST904690890.35
5026Insomnia complaintsGCST0064870.35
5027Other joint disordersFING000010640.35
5028X-24947 levelsGCST902006510.35
5029Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107ECGU0001070.35
5030B4GALT1 levelsGCST904684120.35
5031Operation code - hip replacement/revision | OperationsUKBB000005580.35
5032CCL4 levelsGCST900120520.35
5033wg rh intensity-contrast rostralanteriorcingulateGCST900038520.35
5034FGFBP3 levelsGCST904692320.35
5035AGER levelsGCST900120540.35
5036DepressionFING000003980.35
5037BMP4 levelsGCST904684530.35
5038Wet age-related macular degenerationFING000014480.35
5039aseg lh intensity PallidumGCST900037710.35
5040Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380ECGA0003800.35
5041Platelet countGCST900187490.35
5042Free cholesterol levels in HDLGCST900928240.35
5043CST1 levelsGCST904688930.34
5044IDP dMRI ProbtrackX ICVF fmiGCST900043860.34
5045VSNL1 levelsGCST904710540.34
5046Types of transport used (excluding work) - Public transport | Physical activityUKBB000008780.34
5047INPP1/TBCC ratioGCST903151800.34
5048MAP2K6 levelsGCST904698520.34
5049HBB levelsGCST900259690.34
5050CD19 on IgD- CD27- B cellGCST900017320.34
5051Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11ECGA0000110.34
5052DTI TBSS MD Uncinate fasciculus RGCST903846160.34
5053GRAP2/PTPN6 ratioGCST903149860.34
5054IGLL1 levelsGCST902414730.34
5055aparc-a2009s rh area S-postcentralGCST900034370.34
5056REG4/SPINK4 ratioGCST903157660.34
5057BA-exvivo lh area BA1GCST900032070.34
5058IGFBP4/OGN ratioGCST903151340.34
5059ITGB1/REG1A ratioGCST903152280.34
5060Ever sought or received professional help for mental distress | Mental distressUKBB000002220.34
5061DOK2/PPP1R12A ratioGCST903145360.34
5062Congenital malformations of the circulatory systemFING000003400.34
5063IDP dMRI ProbtrackX L1 slf rGCST900042680.34
5064CD84/SEMA4D ratioGCST903139170.34
5065IDP dMRI ProbtrackX ICVF cst lGCST900043830.34
5066Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104ECGU0001040.34
5067Redundant prepuce, phimosis and paraphimosisFING000012460.34
5068DTI TBSS L3 Retrolenticular part of internal capsule LGCST903845450.34
5069DTI TBSS MD Superior longitudinal fasciculus RGCST903846120.34
5070SRC/STAT5B ratioGCST903158820.34
5071IDP dMRI TBSS ICVF Medial lemniscus LGCST900043360.34
5072Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney diseaseGCST902659710.34
5073Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027630.33
5074Frequency of depressed mood in last 2 weeks | Mental healthUKBB000002590.33
5075EGLN1/PSIP1 ratioGCST903146200.33
5076ACAN levelsGCST904681960.33
5077Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027770.33
5078Bell's palsyFING000001440.33
5079EDAR/SNAP23 ratioGCST903145870.33
5080Type 2 diabetes with ophthalmic manifestations (PheCode 250.23)GCST904756730.33
5081Infections of the skin and subcutaneous tissueFING000006700.33
5082Impacted cerumen (PheCode 380.4)GCST904759010.33
5083EBAG9/TBCC ratioGCST903145680.33
5084CAG-177 sp003538135 abundance in stoolGCST900322600.33
5085T1 FreeSurfer aseg 4th-VentricleGCST903841480.33
5086Triacylglycerol_51:2_[M+NH4]1+ levelsGCST900604970.33
5087eGFR in diabetes mellitus (loose) kidney healthy controls (full adjustment)GCST906247930.33
5088Estimated glomerular filtration rate, cystain C | Other measurementUKBB000002100.33
5089wg lh intensity-contrast isthmuscingulateGCST900038010.33
5090Nontoxic multinodular goiter | endocrine/metabolicUKBB000005280.33
5091RSPO1 levelsGCST904705030.33
5092Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464)GCST902695610.33
5093BACH1/CD2AP ratioGCST903134350.33
5094Lysoalkylphosphatidylcholine (O-24:1) levelsGCST900248130.33
5095RBP7 levelsGCST904704400.33
5096Atrial flutter (PheCode 427.22)GCST904759730.33
5097MATN3 levelsGCST904698650.33
5098Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions)FING000006920.33
5099Thyroiditis, unspecifiedFING000013590.33
5100Treatment/medication code - lisinopril | MedicationsUKBB000008500.33
5101Myocardial fractal dimension (slice 5)GCST900002910.33
5102IDP dMRI TBSS ICVF Posterior corona radiata LGCST900043540.33
5103AHSP levelsGCST904682640.33
5104IDP dMRI TBSS ISOVF Posterior thalamic radiation RGCST900045050.33
5105ELAC1 levelsGCST904691010.33
5106Coxarthrosis [arthrosis of hip] | ArthrosisUKBB000001540.33
5107Porridge likingGCST900948150.33
5108Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST904760650.33
5109ADGRF5 levelsGCST904682390.33
5110Anal and rectal conditions | digestiveUKBB000000290.33
5111estimated glomerular filtration rate (eGFR, mean, inv-norm transformed)GCST904752820.33
5112HDL cholesterolGCST900187360.33
5113HemoglobinGCST900023840.33
5114CRYGD levelsGCST904688760.33
5115USO1 levelsGCST904710180.33
5116Volume of right accessory basal nucleusGCST904750090.33
5117Open wound of foot except toe(s) alone (PheCode 871.3)GCST904762860.33
5118wg lh intensity-contrast superiorparietalGCST900038200.32
5119Urine N-acetyl-cadaverine levels in chronic kidney diseaseGCST902655410.32
5120Age spotsGCST0060960.32
5121Placental weight (fetal genotype, adjusted for sex)GCST902751970.32
5122ALCAM/CDH5 ratioGCST903132340.32
5123FABP1/SULT2A1 ratioGCST903147550.32
5124LAT/MANF ratioGCST903152840.32
5125X-21829 levelsGCST902005850.32
5126Heart valve disorders (PheCode 395)GCST904759130.32
5127Omega-3 fatty acid levelsGCST905020640.32
5128Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382ECGA0003820.32
5129Arachidoylcarnitine (C20) levelsGCST902001350.32
5130Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T61ECGU0000610.32
5131Other peripheral nerve disorders (PheCode 351)GCST904758420.32
5132Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900254340.32
5133DNAJB2 levelsGCST904690130.32
5134IDP dMRI ProbtrackX L3 cst lGCST900043080.32
5135aparc-DKTatlas rh volume superiorparietalGCST900029200.32
5136SPARCL1 levelsGCST902428700.32
5137Birth weightGCST0075570.32
5138T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48)GCST903206110.32
5139Calcium levels (UKB data field 30680)GCST904680650.32
5140aparc-a2009s lh volume G-front-inf-OpercularGCST900029360.32
5141Cardiovascular delta age (difference between ECG-predicted and chronological age)GCST902397490.32
5142aparc-pial rh area TotalSurfaceGCST900031740.32
5143SMAD5 levelsGCST904706780.32
5144Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461ECGA0004610.32
5145Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST903093580.32
5146X-18601 levelsGCST902435010.32
5147CCL15/CCL23 ratioGCST903136810.32
5148Valine levels (UKB data field 23467)GCST902695640.32
5149creatinine (minimum, inv-norm transformed)GCST904752320.32
5150Non-cancer illness code, self-reported - migraine | Medical conditionsUKBB000005200.32
5151Risk taking | Mental healthUKBB000007590.32
5152Urine methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655090.32
5153Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384ECGA0003840.32
5154CEP43 levelsGCST904687150.32
5155Other noninflammatory disorders of uterus, except cervixFING000010790.32
5156Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62ECGU0000620.31
5157IDP dMRI TBSS ICVF Posterior thalamic radiation LGCST900043560.31
5158CCL26 levelsGCST904685780.31
5159EIF2AK2 levelsGCST904690910.31
5160Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T64ECGU0000640.31
5161Coffee max likingGCST900947390.31
5162C3 levelsGCST904684980.31
5163T1 FreeSurfer DK lh superiortemporal thicknessGCST903856510.31
5164CIAPIN1/SNAP29 ratioGCST903140670.31
5165ITGAM/ITGAV ratioGCST903152090.31
5166DKK1/PPCDC ratioGCST903144770.31
5167F-bitter food liking (derived food-liking factor)GCST900947060.31
5168ALB levelsUKBB000000190.31
5169EFHD1 levelsGCST904690790.31
5170hemoglobin (mean, inv-norm transformed)GCST904753740.31
5171Childhood maltreatmentGCST905518320.31
5172Nephrotic syndromeGCST900186640.31
5173Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88ECGA0000880.31
5174Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379ECGA0003790.31
5175aparc-Desikan lh area supramarginalGCST900031030.31
5176BAG6 levelsGCST904684180.31
5177Spleen iron concentrationGCST901018310.31
5178BCAN levelsGCST904684260.31
5179GPI levelsGCST904693910.30
5180Pain type(s) experienced in last month - Hip pain | PainUKBB000006280.30
5181Blood urea nitrogen levelsGCST902786230.30
5182CLEC4D/TGFA ratioGCST903141170.30
5183GALNT10/TNFSF12 ratioGCST903149160.30
5184Diastolic blood pressureGCST902786250.30
5185TSHB levelsGCST904709740.30
5186CELA3A/KIRREL2 ratioGCST903140130.30
5187Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244ECGU0002440.30
5188Lysophosphatidylcholine (22:6) [sn2] levelsGCST900241850.30
5189GCC1 levelsGCST904693150.30
5190COMP levelsGCST904688270.30
5191Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498ECGU0004980.30
5192Cardiac defibrillator in situ (PheCode 426.92)GCST904759610.30
5193Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T118ECGA0001180.30
5194ALCAM/ENPP2 ratioGCST903132360.30
5195CA4 levelsGCST904685130.30
5196Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756630.30
5197DCN levelsGCST904689560.30
5198Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479ECGU0004790.30
5199SPINT1 levelsGCST904707270.30
5200DKK4/REG1B ratioGCST903144900.30
5201LEPR levelsGCST904697560.30
5202PTPRK levelsGCST904703830.30
5203IL13RA1 levelsGCST904695520.30
5204Facial skin colour (CIELAB index b* value)GCST900200560.30
5205Parental longevity (combined parental attained age, Martingale residuals)GCST0066970.30
5206CD46/TNFRSF14 ratioGCST903138380.30
5207Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159ECGU0001590.30
5208Fruit likingGCST900947660.29
5209Pregnancy hypertensionFING000012040.29
5210PMVK/PRDX5 ratioGCST903156940.29
5211ESYT2 levelsGCST904691560.29
5212Phospholipids to total lipids in small HDL percentage (UKB data field 23644)GCST902697410.29
5213APOM/MCAM ratioGCST903133150.29
5214TBCC levelsGCST904708140.29
5215AMY2B levelsGCST904682990.29
5216Omega-3 fatty acids to total fatty acids percentageGCST905024670.29
5217FGD3 levelsGCST904692170.29
5218DECR1/FXN ratioGCST903144460.29
5219Diabetic retinopathy (PheCode 250.7)GCST904756890.29
5220SNX5 levelsGCST904707020.29
5221severe traumatic brain injury, does not include concussionFING000013000.29
5222Alcohol consumption (drinks per month) (UKB data field 1578, 4424)GCST901329920.29
5223CST6/GAL ratioGCST903143020.29
5224wg rh intensity-contrast superiortemporalGCST900038560.29
5225Osteoarthritis; localized | musculoskeletalUKBB000005950.29
5226Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68ECGU0000680.29
5227Nonspecific chest pain | circulatory systemUKBB000005270.29
5228Oily fish consumptionGCST901329930.29
5229Age at onset of walkingGCST906510780.29
5230Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383ECGA0003830.29
5231Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026760.29
5232EPHA2 levelsGCST904691300.29
5233BST1 levelsGCST904684740.29
5234Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026490.29
5235Histidine levelsGCST904974810.29
5236CCL22 levelsGCST904685740.29
5237Thyroxine levelsGCST902002930.29
5238Self-reported risk-taking behaviourGCST0068100.29
5239Other strabismusFING000011140.29
5240Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T70ECGU0000700.29
5241Total Cholesteryl ester levelsGCST900251880.28
5242SCPEP1 levelsGCST904705530.28
5243Degree of unsaturationGCST905027520.28
5244Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivityGCST903027660.28
5245THTPA levelsGCST904708600.28
5246ThalamNuclei rh volume CeMGCST900027510.28
5247Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivityGCST903027200.28
5248aparc-Desikan rh volume superiorparietalGCST900028290.28
5249Deoxycholic acid glucuronide metabolite levelGCST906162290.28
5250CD5/CD6 ratioGCST903138600.28
5251EFNA1/PIK3IP1 ratioGCST903145980.28
5252F-whole food liking (derived food-liking factor)GCST900948680.28
5253Idiopathic goutFING000006580.28
5254Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T476ECGA0004760.28
5255ANKMY2 levelsGCST904683090.28
5256IDP dMRI TBSS L2 Posterior limb of internal capsule LGCST900041420.28
5257Creatinine levels (UKB data field 30700)GCST904680670.28
5258PPIE levelsGCST902422170.28
5259Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions)FING000006940.28
5260Gastrointestinal issues (confirmatory factor analysis Factor 31)GCST903093650.28
5261PALM levelsGCST904701540.28
5262Hearing difficulty problems background noise (UKB data field 2257)GCST900428850.28
5263Mackerel likingGCST900947960.28
5264HEPH levelsGCST904694460.28
5265MMP7 levelsGCST904699210.28
5266CD40LG/MPIG6B ratioGCST903138250.28
5267ThalamNuclei rh volume CMGCST900027420.28
5268Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020690.28
5269PPP1R2 levelsGCST904703040.28
5270rfMRI amplitudes (ICA100 node 35)GCST900046230.28
5271NFKB1 levelsGCST904700370.27
5272Insomnia (PheCode 327.4)GCST904758260.27
5273LRP11 levelsGCST904697960.27
5274CTF1 levelsGCST904689010.27
5275SCARF2/TNFRSF21 ratioGCST903158130.27
5276Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655080.27
5277Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020770.27
5278Haemoglobin concentration (UKB data field 30020)GCST904680740.27
5279Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T58ECGU0000580.27
5280ARHGEF12 levelsGCST904683580.27
5281Alanine aminotransferase levelsGCST900259790.27
5282IDP dMRI ProbtrackX L1 ilf lGCST900042600.27
5283TNIP1 levelsGCST904709250.27
5284HypothyroidismGCST900186420.27
5285APP/PPP1R12A ratioGCST903133300.27
5286ADA levelsGCST904682310.27
5287Glucose (fasting status unknown, maximum, inv-norm transformed)GCST904753290.27
5288BA-exvivo rh area BA4aGCST900032250.27
5289aparc-a2009s rh volume S-postcentralGCST900030650.27
5290Free cholesterol in medium HDL (UKB data field 23570)GCST902696670.27
5291PDGFB/UXS1 ratioGCST903156340.27
5292Spondylosis and allied disorders (PheCode 721)GCST904762350.27
5293BAIAP2 levelsGCST904684190.27
5294Cholesterol to total lipids in very large HDL percentage (UKB data field 23630)GCST902697270.27
5295Arm fat percentage right (UKB data field 23119)GCST904681580.27
5296Plasma argininate* levels in chronic kidney diseaseGCST902648260.27
5297F-cooking flavour liking (derived food-liking factor)GCST900947420.27
5298wg lh intensity-contrast inferiortemporalGCST900038000.27
5299Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14ECGA0000140.27
5300EDAR/ITGB1BP2 ratioGCST903145800.27
5301Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7ECGA0000070.27
5302MMP8/PGLYRP1 ratioGCST903154650.27
5303CD300E/CXCL10 ratioGCST903137960.27
5304Neutrophil countGCST900023520.27
5305ABHD14B/APRT ratioGCST903131370.26
5306BA-exvivo rh volume BA2GCST900028500.26
5307Treatment/medication code - quinine | MedicationsUKBB000008550.26
5308AKR1B1 levelsGCST904682730.26
5309Uterine fibroidsGCST904681540.26
5310HDL cholesterol levels (UKB data field 23406)GCST902695030.26
5311Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457ECGU0004570.26
5312Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney diseaseGCST902642070.26
5313Morbid obesity (PheCode 278.11)GCST904757650.26
5314Triacylglycerol_50:5_[M+NH4]1+ levelsGCST900604630.26
5315TRAF2/WWP2 ratioGCST903159430.26
5316Medication use (agents acting on the renin-angiotensin system)GCST900187680.26
5317DTI TBSS L1 FornixGCST903844330.26
5318CETN2/PRTFDC1 ratioGCST903140300.26
5319MigraineGCST904681420.26
5320Body mass indexGCST0049040.26
5321Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97ECGU0000970.26
5322DTI TBSS MD Cingulum hippocampus RGCST903846080.26
5323BA-exvivo rh area BA3bGCST900032240.26
5324LRIG1 levelsGCST904697940.26
5325HippSubfield rh volume Whole-hippocampusGCST900027110.26
5326IL22 levelsGCST900880660.26
5327Biological Grandparent (paternal): Diabetes / SugarGCST904755490.26
5328Degree of unsaturationGCST905022330.26
5329DTI TBSS L3 Superior longitudinal fasciculus LGCST903845650.26
5330Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004280.26
5331CDCP1/MSR1 ratioGCST903139380.26
5332DAB2/LYN ratioGCST903143650.26
5333TIMP4 levelsGCST904708720.26
5334IDP dMRI TBSS FA Anterior limb of internal capsule LGCST900038940.26
5335T1 FreeSurfer DK rh cuneus areaGCST903856930.26
5336Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133ECGU0001330.26
5337Body mass indexGCST901037510.26
5338Urinary tryptophan to urinary creatinine ratioGCST904517480.26
5339Alcohol frequency weekly (weighted GWA)GCST902672670.26
5340DTI TBSS MD FornixGCST903845770.26
5341QC SWI-to-T1 linear alignment discrepancyGCST900063520.26
5342PLAU levelsGCST904702520.26
5343SDCCAG8 levelsGCST904705600.26
5344CXCL5/SERPINE1 ratioGCST903143540.26
5345Estimated glomerular filtration rate (creatinine, cystatin c)GCST904284460.26
5346Blood cell traits latent factor 8 (white cell)GCST905592500.26
5347Sleep disorders | Episodic and paroxysmal disordersUKBB000007750.26
5348ING1 levelsGCST904696130.26
5349MYBPC1 levelsGCST904699690.25
5350PDGFRB levelsGCST904701920.25
5351Left bundle-branch blockFING000007160.25
5352BLMH/PEAR1 ratioGCST903135190.25
5353Urate | Blood biochemistryUKBB000008840.25
5354IGFBP2 levelsGCST904695280.25
5355rfMRI connectivity (ICA100 edge 961)GCST900058140.25
5356Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)FING000008650.25
5357Fruit intake (standard GWA)GCST902672820.25
5358Principal component-derived dietary pattern 28GCST901330330.25
5359Enterocolitis due to Clostridium difficileFING000005070.25
5360Triacylglycerol_54:4_[M+NH4]1+ levelsGCST900605400.25
5361aparc-DKTatlas lh area parstriangularisGCST900032520.25
5362ENO2/MANF ratioGCST903146620.25
5363DTI TBSS MO Middle cerebellar peduncleGCST903846200.25
5364wg rh intensity-contrast lingualGCST900038390.25
5365Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430ECGU0004300.25
5366TXNDC5 levelsGCST904709910.25
5367FKBP1B levelsGCST904692420.25
5368FSTL3/LTBR ratioGCST903148830.25
5369Acquired toe deformities (PheCode 735.2)GCST904762490.25
5370aparc-a2009s lh area G-precentralGCST900033250.25
5371Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161ECGU0001610.25
5372SEC31A levelsGCST904705630.25
5373MENT levelsGCST904698860.25
5374Disorders of other endocrine glandsFING000004500.25
5375CLEC1B/DAB2 ratioGCST903140860.25
5376Lysoalkylphosphatidylcholine (O-24:2) levelsGCST900254380.25
5377Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490ECGA0004900.25
5378CD69/CHMP1A ratioGCST903138680.25
5379PRDX3 levelsGCST904703170.25
5380Do you currently smoke cigarettes?GCST904763880.25
5381CD276 levelsGCST904686140.25
5382CERT/MAX ratioGCST903140280.25
5383Myocardial fractal dimension (slice 2)GCST900002880.25
5384Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31)GCST904761160.25
5385CCL13/CCL8 ratioGCST903136760.25
5386IDP dMRI TBSS ICVF Tapetum RGCST900043730.25
5387Multi-trait sum scoreGCST902701190.25
5388Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59ECGA0000590.24
5389Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60ECGA0000600.24
5390PARK7 levelsGCST904701590.24
5391NPPC levelsGCST904700750.24
5392Spondylosis without myelopathy (PheCode 721.1)GCST904762360.24
5393Osteopathies and chondropathiesFING000009130.24
5394ENPP7 levelsGCST904691180.24
5395IDP dMRI ProbtrackX OD fmaGCST900044600.24
5396DTI TBSS L2 Sagittal stratum LGCST903845070.24
5397SCARF1/SUSD1 ratioGCST903158110.24
5398Intended management of patient (recoded) - No overnight hospital stay | Summary AdministrationUKBB000003660.24
5399Biliverdin levels in chronic kidney diseaseGCST902574950.24
5400Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143ECGU0001430.24
5401Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARBUKBB000006620.24
5402Calculus of ureter (PheCode 594.3)GCST904761470.24
5403RUNX3 levelsGCST902427060.24
5404Anxiety, nerves or generalized anxiety disorder | Mental distressUKBB000000390.24
5405Hereditary deficiency of other clotting factorsFING000006120.24
5406Telomere length (principal component 2)GCST904351450.24
5407CDHR2/MME ratioGCST903139630.24
5408Left ventricular outflow tract obstruction (LVOTO), broad definitionFING000007170.24
5409aparc-DKTatlas lh volume superiorparietalGCST900028890.24
5410CTRC/KIRREL2 ratioGCST903143090.24
5411DiverticulitisGCST904681250.24
5412ANXA4/LACTB2 ratioGCST903132930.24
5413PSME2/RBKS ratioGCST903157370.24
5414JAM2/TNFRSF21 ratioGCST903152420.24
5415Arm fat percentage left (UKB data field 23123)GCST904681570.24
5416Other serious medical condition/disability diagnosed by doctor | Medical conditionsUKBB000006190.24
5417GFRA1/SPON2 ratioGCST903149230.24
5418wg lh intensity-contrast insulaGCST900038260.24
5419Hemoglobin concentrationGCST0046150.24
5420TMSB10/TRIAP1 ratioGCST903159240.24
5421CNP levelsGCST904687980.24
5422Gastritis and duodenitis | digestiveUKBB000002770.23
5423Estimated glomerular filtration rate (cystatin c)GCST904284480.23
5424Left ventricular outflow tract obstruction, narrow definitionFING000007180.23
5425X-16087 levelsGCST902005370.23
5426Other/unspecified dorsalgiaFING000011240.23
5427EDAR/F2R ratioGCST903145770.23
5428Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605060.23
5429Medication use (glucocorticoids)GCST900187800.23
5430FLT1/TGFB1 ratioGCST903148570.23
5431MIF levelsGCST904699060.23
5432Creatinine | Blood biochemistryUKBB000001560.23
5433PRR4 levelsGCST904703380.23
5434Total cholesterol levelsGCST902396750.23
5435TIMP3/ZBTB16 ratioGCST903159210.23
5436Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivityGCST903026720.23
5437Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434ECGU0004340.23
5438Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)GCST901329670.23
5439Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440ECGU0004400.23
5440Tobacco useFING000013650.23
5441IDP T1 FAST ROIs L postcent gyrusGCST900024830.23
5442Total testosterone levelsGCST905033130.23
5443Soya milk likingGCST900948450.23
5444Raynauds phenomenon diseaseGCST902717130.23
5445Docosahexaenoic acid to total fatty acids percentageGCST905022840.23
5446Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34ECGA0000340.23
5447X-21441 levelsGCST902005810.23
5448SSNA1 levelsGCST904707500.23
5449FKBP5 levelsGCST904692440.23
5450Treatment/medication code - paracetamol | MedicationsUKBB000008530.23
5451ERBIN/SIRT2 ratioGCST903146960.23
5452High-grade serous epithelial ovarian cancerGCST902441680.23
5453Beer or cider consumption (glasses per month) (UKB data field 1578, 4420)GCST901329880.23
5454IDP dMRI TBSS OD Posterior limb of internal capsule RGCST900044200.23
5455Varicose veinsGCST900861440.23
5456Cellulitis and abscess of leg, except foot (PheCode 681.5)GCST904761660.23
5457Other mental disorder | mental disordersUKBB000006140.22
5458Chronic obstructive pulmonary disease in ever smokersGCST900165880.22
5459NOTCH1 levelsGCST904700650.22
5460Fracture of femurFING000005520.22
5461Volume of left medial nucleusGCST904748920.22
5462IDP dMRI ProbtrackX ISOVF unc rGCST900045510.22
5463Glycine levelsGCST0076380.22
5464APRT levelsGCST904683450.22
5465TNFRSF10B levelsGCST900120210.22
5466Number of non-cancer illnesses (weighted GWA)GCST902672910.22
5467HGF/MMP9 ratioGCST903150560.22
5468Trihexosylcermide (d18:1/18:0) levelsGCST900247380.22
5469Principal component-derived dietary pattern 1GCST901330060.22
5470KIR2DL3 levelsGCST904696850.22
5471Cereal intake | DietUKBB000001210.22
5472Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)GCST900276380.22
5473Mother's age | Family historyUKBB000004840.22
5474Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T79ECGA0000790.22
5475DCTN6/TDRKH ratioGCST903144360.22
5476T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903208640.22
5477Blood cell traits latent factor 21 (red cell)GCST905592630.22
5478DTI autoptx FA ilf l tractGCST903851260.22
5479Triglyceride levels in chylomicrons and extremely large VLDLGCST901326300.22
5480Low density lipoprotein cholesterol levelsGCST902786380.22
5481CRTAC1 levelsGCST904688700.22
5482Bread type - White | DietUKBB000001060.22
5483F7/VASN ratioGCST903147450.22
5484Anti-human herpes virus 6 IE1A IgG seropositivityGCST900069030.22
5485DTI autoptx MD slf r tractGCST903852420.22
5486CD2AP levelsGCST904686170.22
5487Volume of left cortical nucleusGCST904749640.22
5488C1QTNF9 levelsGCST904684910.22
5489ENDOU levelsGCST904691070.22
5490CRKL/PLA2G4A ratioGCST903142710.22
5491BMP10 levelsGCST904684520.22
5492X-12095--N1-methyl-3-pyridone-4-carboxamide levelsGCST902437010.22
5493IDP T1 FAST ROIs L cerebellum XGCST900025870.22
5494Number of correct matches in round | Pairs matchingUKBB000005320.22
5495TOMM20 levelsGCST904709310.22
5496Weight (UKB data field 21002)GCST904681830.22
5497Diffuse idiopathic skeletal hyperostosis flow scoreGCST901345320.22
5498HNRNPAB levelsGCST900886930.22
5499Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T232ECGU0002320.22
5500IDP dMRI ProbtrackX ISOVF cgc rGCST900045300.22
5501Disorders of lacrimal systemFING000004410.22
5502PRTN3 levelsGCST904703480.22
5503BCR/CLIP2 ratioGCST903134860.22
5504Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475ECGA0004750.22
5505Diabetes / SugarGCST904752650.22
5506ICD10 O14: Pre-eclampsiaGCST904542330.22
5507Hearing difficulty/problems with background noise | HearingUKBB000003120.21
5508Left-hemisphere control network to accumbens white-matter structural connectivityGCST903027580.21
5509Nontoxic diffuse goitreFING000008860.21
5510Witnessed sudden violent death | Traumatic eventsUKBB000009170.21
5511Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51ECGA0000510.21
5512FLT3/FLT3LG ratioGCST903148590.21
5513GP2/LGALS8 ratioGCST903149610.21
5514LGALS3 levelsGCST901793030.21
5515DNAJB14 levelsGCST904690110.21
5516Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79ECGU0000790.21
5517Skin colour | Sun exposureUKBB000007730.21
5518high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST904753480.21
5519Acute pulmonary heart disease (PheCode 415.1)GCST904759440.21
5520DTI autoptx MD atr l tractGCST903852220.21
5521aseg rh intensity Thalamus-ProperGCST900037820.21
5522Phosphate levelsGCST902003930.21
5523Left ventricular end-systolic volumeGCST902681260.21
5524ABHD14B/SCRN1 ratioGCST903131450.21
5525PDIA4 levelsGCST904701950.21
5526Usual walking pace | Physical activityUKBB000008910.21
5527DTI TBSS L2 Posterior corona radiata RGCST903845020.21
5528DLL1 levelsGCST904690040.21
5529Weight (mean, inv-normal transformed)GCST904764630.21
5530Chronic ulcer of skin (PheCode 707)GCST904762160.21
5531Total bilirubin levelsGCST902786430.21
5532FURIN/IGSF3 ratioGCST903148850.21
5533aparc-a2009s rh volume G+S-subcentralGCST900030020.21
5534Pain type(s) experienced in last month - None of the above | PainUKBB000006310.21
5535ACVRL1/EFNA4 ratioGCST903131560.21
5536YWHAQ levelsGCST904710920.21
5537DKK1/LGALS8 ratioGCST903144720.21
55381-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levelsGCST902003300.21
5539LYN/TACC3 ratioGCST903153500.21
5540C2/SSC5D ratioGCST903135550.21
5541ANGPTL1 levelsGCST904683020.21
5542EIF4G1/HEXIM1 ratioGCST903146350.21
5543GSTA3/KRT18 ratioGCST903149970.21
5544EREG/ITGB1BP2 ratioGCST903147030.20
5545PPP1R14D levelsGCST904703030.20
5546NECTIN4/TGFBR2 ratioGCST903155350.20
5547PLA2G10 levelsGCST904702440.20
5548CSTB levelsGCST904688980.20
5549Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428ECGU0004280.20
5550Volume of left paralaminar nucleusGCST904749850.20
5551TRIM40 levelsGCST904709680.20
5552Bread type: White (UKB data field 1448_1)GCST901329640.20
55531-arachidonoylglycerophosphoethanolamine levelsGCST902438080.20
5554Duration of walks | Physical activityUKBB000002000.20
5555Treatment or medication use - amlodipine (UKB data field 20003_1140879802)GCST900421950.20
5556CXCL12 levelsGCST904689250.20
5557PTPN1/SCAMP3 ratioGCST903157430.20
5558aparc-DKTatlas rh area parsopercularisGCST900032810.20
5559Venous thromboembolismGCST903997440.20
5560Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462ECGA0004620.20
5561Nerve, nerve root and plexus disordersFING000008620.20
5562Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivityGCST903027640.20
5563Total protein levelsUKBB000008260.20
5564CRHBP/TREM2 ratioGCST903142600.20
5565CCL18/TFPI ratioGCST903136910.20
5566BleedingFING000002190.20
5567FCRL2 levelsGCST904692060.20
5568DTI TBSS L2 Anterior corona radiata LGCST903844990.20
5569BAP18 levelsGCST904684220.20
5570AHCY levelsGCST904682590.20
5571F-salty food liking (derived food-liking factor)GCST900948270.20
5572Operation code - anterior/posterior repair bladder/uterus | OperationsUKBB000005480.20
5573Dissection of aortaFING000004670.20
5574Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33ECGA0000330.20
5575CD48 levelsGCST904256760.20
5576Triacylglycerol (52:4) [NL-16:0] levelsGCST900251700.20
5577T1 FreeSurfer a2009s rh G cuneus volumeGCST903850480.20
5578Major depressive disorder (ICD-10 coded)GCST0059030.20
5579DTI autoptx L3 slf l tractGCST903852140.20
5580PSG1 levelsGCST904703530.20
5581DTI autoptx L2 slf r tractGCST903851880.20
5582Ever had period extreme irritability | ManiaUKBB000002170.20
5583Other and unspecified polyneuropathies, also in other diseasesFING000009480.20
5584Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243ECGU0002430.20
5585Vitamin D | Blood biochemistryUKBB000009020.20
5586CLEC1B/EGF ratioGCST903140890.20
5587REST UKBBICA NODEamps25 0003GCST903854860.20
5588CLEC1B/LGALS8 ratioGCST903140960.20
5589OPHN1 levelsGCST904701260.20
5590Glucose (fasting status unknown, mean, inv-norm transformed)GCST904753320.20
5591Ankylosing spondylitis, strict definitionFING000000900.19
5592Ceramide (d17:1/22:0) levelsGCST900240320.19
5593STIP1/TMSB10 ratioGCST903158900.19
5594CEP43/PLXNB3 ratioGCST903140200.19
5595SERPINB8 levelsGCST904705920.19
5596PITHD1 levelsGCST904702390.19
5597TBCB/TBCC ratioGCST903159090.19
5598Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467ECGU0004670.19
5599Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21ECGA0000210.19
5600Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103ECGU0001030.19
5601C4 levelsGCST902810420.19
5602DTI TBSS MD Fornix cres+Stria terminalis RGCST903846100.19
5603MGLL/MITD1 ratioGCST903154360.19
5604CD20 on IgD- CD27- B cellGCST900017540.19
5605METAP1D/VASH1 ratioGCST903154290.19
5606aparc-DKTatlas lh area superiorparietalGCST900032610.19
5607THBD levelsGCST904708530.19
5608Plasma methylsuccinate levels in chronic kidney diseaseGCST902655060.19
5609CERT/PRTFDC1 ratioGCST903140290.19
5610red cell diameter width (RDW, maximum, inv-norm transformed)GCST904763550.19
5611PDLIM5 levelsGCST904701970.19
5612TTR levelsGCST904709850.19
5613Omega-3 fatty acid levelsGCST905024410.19
5614CDKN2D levelsGCST904686850.19
5615ALB levelsGCST900187250.19
5616aparc-Desikan lh area postcentralGCST900030940.19
5617CTRC levelsGCST904689060.19
5618EGLN1/LSP1 ratioGCST903146170.19
5619IDP dMRI TBSS OD Genu of corpus callosumGCST900044040.19
5620QC T1-to-standard nonlinear alignment discrepancyGCST900063460.19
5621DTI TBSS L3 Superior longitudinal fasciculus RGCST903845640.19
5622FBP1/GSTA1 ratioGCST903147860.19
5623Polyunsaturated fatty acids to total fatty acids percentageGCST905026480.19
5624IDP dMRI ProbtrackX ICVF fmaGCST900043850.19
5625IGF1R levelsGCST904695240.19
5626LBR levelsGCST904697440.19
5627GBP2 levelsGCST904693120.19
5628Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levelsGCST900603110.19
5629EPHB4/ESAM ratioGCST903146790.19
5630GPC5 levelsGCST904693870.19
5631Phospholipid levels in large HDLGCST900928520.19
5632Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242ECGU0002420.19
5633high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753520.19
5634aparc-a2009s lh area G-postcentralGCST900033240.19
5635Octadecenedioate (C18:1-DC) levelsGCST902001650.19
5636CMC1 levelsGCST904687940.19
5637Pancreas volumeGCST900166690.18
5638OTUD6B levelsGCST904701360.18
5639Hypopotassemia (PheCode 276.14)GCST904757550.18
5640Neutrophill count | Blood countUKBB000004970.18
5641Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486ECGA0004860.18
5642Cholesteryl esters in HDL (UKB data field 23418)GCST902695150.18
5643LRRC59 levelsGCST904698040.18
5644Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469ECGU0004690.18
5645CD46/NID1 ratioGCST903138330.18
5646ADA2/VCAM1 ratioGCST903131670.18
5647Secondary thrombocytopenia (PheCode 287.32)GCST904758100.18
5648Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497ECGU0004970.18
5649Job involves heavy manual or physical work | EmploymentUKBB000003830.18
5650Total lipids in large HDL (UKB data field 23559)GCST902696560.18
5651NFX1 levelsGCST904700410.18
5652MED18/SH2B3 ratioGCST903154120.18
5653Estimated glomerular filtration rate, serum creatinine | Other measurementUKBB000002120.18
5654Glomerular filtration rate in non diabetics (creatinine)GCST0034010.18
5655Treatment speciality of consultant (recoded) - General surgery | Summary AdministrationUKBB000008340.18
5656T1 FreeSurfer DK lh precentral thicknessGCST903856450.18
5657eGFR in diabetes mellitus (strict) case-control group (minimal adjustment)GCST906247810.18
5658IL17A levelsGCST904695580.18
5659INSR levelsGCST902415090.18
5660AZU1 levelsGCST904684080.18
5661CDHR2 levelsGCST904686790.18
5662aparc-DKTatlas rh area precentralGCST900032870.18
5663Urine N-acetylglutamate levels in chronic kidney diseaseGCST902655690.18
5664ERBIN/SNAP29 ratioGCST903146970.18
5665ACRBP levelsGCST904682050.18
5666Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levelsGCST900603070.18
5667Triacylglycerol_53:3_[M+NH4]1+ levelsGCST900605280.18
5668GP2/SELE ratioGCST903149620.18
5669CD40LG/TRAF2 ratioGCST903138280.18
5670Hypertensive heart and/or renal disease (PheCode 401.2)GCST904759240.18
5671Smoked fish likingGCST900948410.18
5672DTI autoptx MD cgc r tractGCST903852250.18
5673PARK7/TNFRSF9 ratioGCST903155990.18
5674BA-exvivo rh area BA1GCST900032210.18
5675AMY2A levelsGCST904682980.18
5676aparc-pial rh area parstriangularisGCST900031930.18
5677Treatment/medication code - ibuprofen | MedicationsUKBB000008470.18
5678FGR/LBR ratioGCST903148140.18
5679ANGPT1/CCN2 ratioGCST903132610.18
5680Ulcerative colitisGCST900187130.18
5681IDP dMRI ProbtrackX L1 ifo rGCST900042590.18
5682CTSE levelsGCST904689110.18
5683Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481ECGA0004810.18
5684DAG1/PDGFA ratioGCST903143780.18
5685Hereditary ataxiaFING000006100.18
5686COL1A1/SOST ratioGCST903141720.18
5687DARS1/EIF4B ratioGCST903144030.18
5688Gout (PheCode 274.1)GCST904757350.18
5689Current tobacco smoking | SmokingUKBB000001610.18
5690ERN1 levelsGCST904691480.18
5691HYOU1/ROR1 ratioGCST903151040.18
5692DAG1/GP6 ratioGCST903143750.18
5693STAMBP levelsGCST904707560.17
5694Lysophosphatidylethanolamine-P_20:0_[M-H]1- levelsGCST900601470.17
5695Triacylglycerol_53:5_[M+NH4]1+ levelsGCST900605200.17
5696SELPLG levelsGCST900120460.17
5697CERT levelsGCST904687170.17
5698ERP29 levelsGCST904691490.17
5699CD200/CNTNAP2 ratioGCST903137470.17
5700Psoriatic arthropathiesFING000012250.17
5701CD38 levelsGCST904686280.17
5702MDH1 levelsGCST904698760.17
5703Major dietary changes in the last 5 years - Yes, because of illness | DietUKBB000004220.17
5704Propionylcarnitine levelsGCST902435930.17
5705Triglyceride to phosphoglyceride ratioGCST904544830.17
5706Administrative and legal statuses - NHS patient: not formally detained | Summary AdministrationUKBB000000120.17
5707eGFR in diabetes mellitus (full adjustment)GCST906247860.17
5708PCSK9 levelsGCST904281100.17
5709Free cholesterol in large HDL (UKB data field 23563)GCST902696600.17
5710GFRA3 levelsGCST904693300.17
5711Fasting blood glucoseGCST0005680.17
5712DCTD levelsGCST904689570.17
5713BMPER levelsGCST904684550.17
5714GFRA2 levelsGCST904693290.17
5715Fracture of upper limb (PheCode 803)GCST904762790.17
5716CLSTN2 levelsGCST904687890.17
5717ALCAM/NOTCH1 ratioGCST903132410.17
5718MCAM/NTRK3 ratioGCST903154090.17
5719Retinal nerve fibre layer (RNFL) thicknessGCST900142660.17
5720Smoking status - Current | SmokingUKBB000007790.17
5721Risk taking (standard GWA)GCST902672980.17
5722CRADD levelsGCST904688540.17
5723Adhesive capsulitis of shoulderFING000000430.17
5724Degree of unsaturationGCST905027360.17
5725IDP T1 SIENAX brain-unnormalised volumeGCST900024350.17
5726CD200R1/CLEC4G ratioGCST903137480.17
5727GART levelsGCST904693030.17
5728CCL14 levelsGCST904685660.17
5729aparc-a2009s rh volume G-postcentralGCST900030260.17
5730CXCL16 levelsGCST900120590.17
5731CASP8 levelsGCST904685480.17
5732DTI TBSS L1 Posterior limb of internal capsule RGCST903844460.17
5733RAP1A levelsGCST904704250.17
5734MET/PTPRF ratioGCST903154350.17
5735creatinine (mean, inv-norm transformed)GCST904752290.16
5736MAVS/SCAMP3 ratioGCST903153960.16
5737MANF levelsGCST904698460.16
5738Herring likingGCST900947810.16
5739Substance dependenceGCST900187040.16
5740FGFR2 levelsGCST904692330.16
5741red blood cell count (RBC, minimum, inv-norm transformed)GCST904763530.16
5742VPS37A levelsGCST904710460.16
5743Hip circumferenceGCST902786330.16
5744ITGB1/MCAM ratioGCST903152260.16
5745RNASE3 levelsGCST904704770.16
5746CASP3/PDGFB ratioGCST903136380.16
5747HTRA2 levelsGCST904694940.16
5748CRELD2/ERP44 ratioGCST903142530.16
5749Belittlement by partner or ex-partner as an adult | Traumatic eventsUKBB000000910.16
5750SLC35G2 levelsGCST902428570.16
5751ESAM/TNFRSF14 ratioGCST903147200.16
5752Total cholesterol levelsGCST902786440.16
5753Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81ECGA0000810.16
5754DTI TBSS L3 Retrolenticular part of internal capsule RGCST903845440.16
5755Cardiovascular diseaseGCST900860570.16
5756HDLBP levelsGCST900875330.16
5757DOK2/SNX9 ratioGCST903145390.16
5758QDPR levelsGCST904704000.16
5759Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427ECGU0004270.16
5760AHSA1 levelsGCST904682620.16
5761CTSD/PRCP ratioGCST903143120.16
5762AXIN1/HEXIM1 ratioGCST903134080.16
5763PPP1R12A/SPARC ratioGCST903157120.16
5764TCN1 levelsGCST904708190.16
5765SSC4D levelsGCST904707470.16
5766FUCA1 levelsGCST904692750.16
5767Enteritis due to Yersinia enterocoliticaFING000005050.16
5768MTHFSD levelsGCST904699560.16
5769Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491ECGU0004910.16
5770PROS1 levelsGCST904703370.16
5771Other diseases of the respiratory systemFING000010110.16
5772Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42ECGA0000420.16
5773CLEC1B/VTA1 ratioGCST903141070.16
5774Coronary heart diseaseGCST0009980.16
5775Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20ECGA0000200.16
5776aparc-DKTatlas lh area precentralGCST900032560.16
5777S100A14 levelsGCST904705150.16
5778Left ventricular end diastolic massGCST902681230.16
5779AXL levelsGCST904684060.16
5780Free cholesterol to total lipids in small HDL percentage (UKB data field 23647)GCST902697440.16
5781T1 FreeSurfer DKT lh precentral thicknessGCST903842460.16
5782UrolithiasisGCST900187150.16
5783CD27/CD79B ratioGCST903137700.16
5784Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis?GCST904752730.16
5785Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484ECGU0004840.16
5786RTBDN levelsGCST904705050.16
5787Occupational creativityGCST903087740.16
5788aseg rh volume CerebralWhiteMatterGCST900026320.16
5789Vanillylmandelate (VMA) levelsGCST902003090.16
5790DTI autoptx L1 ifo r tractGCST903851520.16
5791DTI autoptx L2 atr l tractGCST903851680.16
5792GNLY/GZMA ratioGCST903149490.16
5793TRIM58 levelsGCST904709690.16
5794BSG/LAMP3 ratioGCST903135330.16
5795ICD10 O24.4: Diabetes mellitus arising in pregnancyGCST904542360.16
5796CDHR5 levelsGCST904686800.16
5797CDH6 levelsGCST904686770.16
5798Flavonifractor sp002159265 abundance in stoolGCST900324000.16
5799DTI TBSS L2 Cingulum hippocampus LGCST903845130.16
5800Word interpolation | Fluid intelligence / reasoningUKBB000009180.16
5801IL19 levelsGCST904695680.16
5802AXIN1/MAP2K6 ratioGCST903134130.16
5803CPXM1/MDK ratioGCST903142210.16
5804CSF1/SEMA3F ratioGCST903142880.16
5805Tooth agenesis EXCLUDE clefts and syndromesFING000013680.16
5806LGMN/TIMP1 ratioGCST903153250.15
5807Atopic dermatitisGCST900271610.15
5808Fasting glucoseGCST900022320.15
5809TFF3 levelsGCST904708370.15
5810PDLIM7/TBC1D23 ratioGCST903156400.15
5811NRGN levelsGCST904700830.15
5812CD69/CDKN2D ratioGCST903138660.15
5813Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12ECGA0000120.15
5814LRCH4 levelsGCST904697910.15
5815CDH2/SSC4D ratioGCST903139510.15
5816CRADD/EREG ratioGCST903142360.15
5817IDP dMRI ProbtrackX MD ptr rGCST900042390.15
5818HEG1 levelsGCST904694440.15
5819Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470ECGA0004700.15
5820Neutrophill count (UKB data field 30140)GCST904680920.15
5821CKMB levelsGCST904752210.15
5822TREML2 levelsGCST904709620.15
5823EGF/GP6 ratioGCST903146080.15
58242,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levelsGCST902002330.15
5825IDP dMRI ProbtrackX L1 str lGCST900042690.15
5826APOA1 levelsGCST902695370.15
5827GSTA1/KRT18 ratioGCST903149930.15
5828DTI autoptx L2 ilf r tractGCST903851810.15
5829MAP3K5/MAVS ratioGCST903153790.15
5830SEPTIN3 levelsGCST904705760.15
5831Falls in the last year | General healthUKBB000002350.15
5832IDP T1 SIENAX brain-normalised volumeGCST900024340.15
5833CCN1 levelsGCST904685870.15
5834Operative procedures - Direct current cardioversion | Summary OperationsUKBB000005760.15
5835ANGPT1/CPXM1 ratioGCST903132620.15
5836IDP dMRI TBSS ICVF Cingulum cingulate gyrus LGCST900043620.15
5837IDP dMRI TBSS L1 Posterior corona radiata LGCST900041020.15
5838Pre-eclampsia or poor fetal growthFING000012020.15
5839IDP T1 FAST ROIs L cerebellum I-IVGCST900025620.15
5840Other disorders of the musculoskeletal system and connective tissueFING000010380.15
5841SMAD2 levelsGCST904706760.15
5842aparc-a2009s rh area G-precentralGCST900033990.15
5843Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB000004660.15
5844T1 CAT volume R SupramarginalGyrusanteriordivisionGCST903840370.15
5845IDP dMRI TBSS MD Cerebral peduncle LGCST900040420.15
5846PTRHD1 levelsGCST904703890.15
5847Rosacea (PheCode 695.3)GCST904761780.15
5848What is your weight? (pounds, inv-normal transformed)GCST904764690.15
5849APP/CD40LG ratioGCST903133190.15
5850T1 FreeSurfer DKT rh insula areaGCST903843170.15
5851Principal component-derived dietary pattern 42GCST901330470.15
5852Systolic blood pressureGCST902786420.15
5853Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472ECGU0004720.15
5854LRPAP1 levelsGCST904698000.15
5855Hemoglobin A1c (HbA1c, maximum, inv-norm transformed)GCST904750910.15
5856Chronic ulcer of leg or foot (PheCode 707.2)GCST904762180.15
5857EDAR/EGF ratioGCST903145730.15
5858NTF3 levelsGCST904700940.15
5859DGKA levelsGCST904689890.15
5860HippSubfield lh volume Whole-hippocampal-bodyGCST900026870.15
5861PTS levelsGCST904703900.15
5862aparc-a2009s rh volume S-oc-middle+LunatusGCST900030550.15
5863HS6ST1 levelsGCST904694790.15
5864DTI TBSS MD Anterior corona radiata RGCST903845940.15
5865DTI TBSS MD Sagittal stratum RGCST903846020.15
5866REST UKBBICA NODEamps25 0007GCST903854900.15
5867DTI autoptx L3 unc r tractGCST903852190.15
5868FAM20A levelsGCST904691850.15
5869Coffee type - Instant coffee | DietUKBB000001410.15
5870Physical decline (log-difference score)GCST905658470.15
5871CD40/CRELD2 ratioGCST903138110.15
5872Principal component-derived dietary pattern 2GCST901330070.15
5873F7/F9 ratioGCST903147430.15
5874PTPRB levelsGCST904703790.15
5875PLSCR3 levelsGCST904702610.15
5876FCER2/TREML2 ratioGCST903147920.15
5877EFCAB14 levelsGCST904690760.15
5878IDP dMRI TBSS ICVF Fornix cres+Stria terminalis LGCST900043660.15
5879LAYN levelsGCST904697420.15
5880Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480ECGU0004800.14
5881Hemoglobin A1c (HbA1c, mean, inv-norm transformed)GCST904750940.14
5882PPP1R14A levelsGCST904703020.14
5883ESAM/PDGFB ratioGCST903147140.14
5884PLA2G4A/SNX9 ratioGCST903156700.14
5885GZMA/TNFRSF4 ratioGCST903150130.14
5886Concentration of large HDL particles (UKB data field 23558)GCST902696550.14
5887CD69 levelsGCST904686430.14
5888aseg lh volume CerebralWhiteMatterGCST900026150.14
5889Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759840.14
5890PLPBP levelsGCST904702600.14
5891FLT1/TFPI2 ratioGCST903148560.14
5892Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB000006000.14
5893GMPR2 levelsGCST904693670.14
5894KeloidGCST900186540.14
5895KRT18 levelsGCST904697160.14
5896CD20 on IgD- CD38- B cellGCST900017550.14
5897ABO levelsGCST904681910.14
5898CLEC1B/MPIG6B ratioGCST903140980.14
5899Fresh fruit intake | DietUKBB000002720.14
5900ROR1/THBD ratioGCST903157860.14
5901PLCB2 levelsGCST904702550.14
5902FKBP5/MITD1 ratioGCST903148440.14
5903HDL cholesterol levelsGCST900928220.14
5904TAFA5 levelsGCST904708000.14
5905MAN1A2 levelsGCST904698430.14
5906MYOM2 levelsGCST904699850.14
5907HBEGF levelsGCST902413920.14
5908ADM levelsGCST904682460.14
5909Duration of vigorous activity | Physical activityUKBB000001990.14
5910Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39ECGA0000390.14
5911SIRT2/STAT5B ratioGCST903158460.14
5912SYTL4 levelsGCST904707950.14
5913COMT levelsGCST904688280.14
5914BCR/ICA1 ratioGCST903134930.14
5915Eosinophil percentage of white cells varianceGCST905656900.14
5916Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004450.14
5917Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480ECGA0004800.14
5918EBAG9/EDAR ratioGCST903145630.14
5919S100A11/SERPINB8 ratioGCST903157990.14
5920COMP/ITGAV ratioGCST903141900.14
5921Insomnia complaintsGCST0046950.14
5922FAM3B/GPA33 ratioGCST903147780.14
5923VASN levelsGCST904710270.14
5924aparc-Desikan lh area parstriangularisGCST900030920.14
5925aparc-a2009s rh volume G-parietal-supGCST900030250.14
5926T1 FreeSurfer aseg Left-Inf-Lat-VentGCST903841400.14
5927CMIP levelsGCST904687950.14
5928NT5C1A levelsGCST904700900.14
5929GNLY levelsGCST904693720.14
5930Pulmonary heart disease (PheCode 415)GCST904759420.14
5931NELL1 levelsGCST904700260.14
5932UFD1 levelsGCST904710050.14
5933SCN4B levelsGCST904705510.14
5934FABP1/LGALS4 ratioGCST903147520.14
5935Ptosis of eyelidFING000012270.14
5936MGLL/STK4 ratioGCST903154430.14
5937Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903026770.13
5938aparc-Desikan lh volume superiorparietalGCST900027960.13
5939KITLG/PLTP ratioGCST903152520.13
5940CALB2 levelsGCST904685270.13
5941BCAN/MOG ratioGCST903134800.13
5942Colon cancer (PheCode 153.2)GCST904755670.13
5943Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98ECGU0000980.13
5944Weight (maximum, inv-normal transformed)GCST904764600.13
5945DyslipidemiaGCST900860770.13
5946KLK6/MOG ratioGCST903152550.13
5947IDP dMRI TBSS MD Posterior corona radiata LGCST900040540.13
5948GRP levelsGCST902412420.13
5949RWDD1 levelsGCST904705100.13
5950Phosphatidate_34:2_[M-H]1- levelsGCST900602230.13
5951BLVRB/HBQ1 ratioGCST903135250.13
5952IFNGR1 levelsGCST904695130.13
5953Pregnenediol disulfate (C21H34O8S2) levelsGCST901998400.13
5954LTA/LTBR ratioGCST903153360.13
5955DTX3 levelsGCST904690480.13
5956Biliary cirrhosis, NASFING000002130.13
5957DLL1/TGFBR2 ratioGCST903144990.13
5958RBKS levelsGCST904704330.13
5959DTI TBSS L3 Cingulum hippocampus RGCST903845600.13
5960MGLL levelsGCST904699010.13
5961KLRK1 levelsGCST904697130.13
5962SHBG levelsGCST905033150.13
59631-stearoyl-2-linoleoyl-GPI (18:0/18:2) levelsGCST902000670.13
5964FABP4 levelsGCST904691760.13
5965Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB000000830.13
5966GALNT10/IGSF3 ratioGCST903149140.13
5967T1 FreeSurfer BA rh V2 exvivo thicknessGCST903855710.13
5968IL16 levelsGCST902415960.13
5969FST levelsGCST900120800.13
5970LY6D levelsGCST904698210.13
5971Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479ECGA0004790.13
5972Frailty indexGCST900200530.13
5973IDP T1 SIENAX grey unnormalised volumeGCST900024310.13
5974Noninfectious disorders of lymphatic channels (PheCode 450)GCST904760020.13
5975EIF4B/MAP4K5 ratioGCST903146230.13
5976FAS levelsGCST900907010.13
5977IDP dMRI TBSS ICVF Posterior limb of internal capsule RGCST900043450.13
5978IGSF8/NECTIN2 ratioGCST903151400.13
5979Transient ischemic attackFING000013750.13
5980aseg lh volume PallidumGCST900026230.13
5981wg rh intensity-contrast transversetemporalGCST900038600.13
5982SSC4D/TNFSF10 ratioGCST903158870.13
5983T1 FreeSurfer BA rh BA3b exvivo areaGCST903855500.13
5984Free cholesterol to total lipids ratio in very large HDLGCST900930090.13
5985F2R/SEMA4D ratioGCST903147340.13
5986Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496ECGU0004960.13
5987Serum 25-Hydroxyvitamin D level varianceGCST900006210.13
5988AK1 levelsGCST904682690.13
5989CREG1/GUSB ratioGCST903142490.13
5990Free cholesterol to total lipids ratio in medium HDLGCST900928970.13
5991AsthmaGCST900185750.13
5992aparc-a2009s lh area G-parietal-supGCST900033230.13
5993DTI autoptx MD slf l tractGCST903852410.13
5994TEK levelsGCST900120130.13
5995MCEMP1 levelsGCST904698720.13
5996GP6 levelsGCST904693840.13
5997IDP dMRI ProbtrackX L1 fmiGCST900042570.13
5998aparc-pial lh area postcentralGCST900031620.13
5999CPXM1/DKK1 ratioGCST903142180.13
6000Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivityGCST903027930.13